43rd EDRN Steering Committee Meeting (Day 3)

Agenda

Wednesday, September 25, 2024 (7:00 a.m. – 6:45 p.m.)

Central Daylight Time Agenda Item

7:00 a.m. – 8:00 a.m.

Sign-in
Room: Truhlsen Events Center Foyer
619 S 42nd St, Omaha, NE 68198

General Session: Truhlsen Events Center, Room: 1001 A

8:00 a.m. – 9:30 a.m.

Early Onset Cancers

8:00 a.m. – 8:20 a.m.

Early Onset Breast Cancer

  • 01: Karen Anderson, MD, PhD, Arizona State University

8:20 a.m. – 8:40 a.m.

Colorectal Cancer

  • 02: Aasma Shaukat, MD, MPH, New York University

8:40 a.m. – 9:00 a.m.

Overview of Increasing Prevalence

  • 03: Ruth Etzioni, PhD, Fred Hutchinson Cancer Center

9:00 a.m. – 9:30 a.m.

Q&A

9:30 a.m. – 9:40 a.m.

Break

9:40 a.m. – 11:40 a.m.

Making Clinical Biomarker Assays for the CLIA Certified Lab: A Practical Guide

9:40 a.m. – 9:55 a.m.

9:55 a.m. – 10:00 a.m. Q&A

How to setup a CLIA certified lab for cancer biomarker testing

  • 04: Andy Hoofnagle, MD, PhD University of Washington

10:00 a.m. – 10:15 a.m.

10:15 a.m. – 10:20 a.m. Q&A

Design and Development of Clinical Biomarker Tests for a CLIA Lab

  • 05: Stefani Thomas, PhD, University of Minnesota

10:20 a.m. – 10:35 a.m.

10:35 a.m. – 10:40 a.m. Q&A

Use of RUOs on Clinical Platforms to Support Early Trials in Clinical Evidence Expansion

  • 06: Gerard Davis, PhD, Abbott Laboratories

10:40 a.m. – 10:55 a.m

10:55 a.m. – 11:00 a.m. Q&A

Case Study and Real-world Applications

  • 07: Arul Chinnaiyan, MD, PhD, University of Michigan

11:00 a.m. – 11:15 a.m.

11:15 a.m. – 11:20 a.m. Q&A

FDA Clearance of AI Devices for Medical Images

  • 08: Bill Lotter, PhD, Dana-Farber Cancer Institute (Remote Presenter)

11:20 a.m. – 11:40 a.m.

Panel Discussion

Chair: Andy Hoofnagle, MD, PhD, University of Washington

11:40 a.m. – 12:30 p.m.

Discussion of the Cancer Biomarkers AI and Bioinformatics Workshop, August 13–15, 2024

  • 09: Dan Crichton, MS, NASA Jet Propulsion Laboratory

12:30 p.m. – 12:40 p.m.

Q & A

12:40 p.m. – 2:00 p.m.

Lunch (On Your Own)

2:00 p.m. – 3:20 p.m.

Collaborative Group Updates

Room: Truhlsen Events Center, Room 1001 A

2:00 p.m. – 2:15 p.m.

2:15 p.m. – 2:20 p.m. Q&A

Breast and Gynecological Cancers

  • 10: Co-chair: Chris Li, MD, PhD, Fred Hutchinson Cancer Center

2:20 p.m. – 2:35 p.m.

2:35 p.m. – 2:40 p.m. Q&A

Lung and Upper Aerodigestive Cancers

  • 11: Co-chair: Marc Lenburg, PhD, Boston University

2:40 p.m. – 2:55 p.m.

2:55 p.m. – 3:00 p.m. Q&A

Prostate and Urologic Cancers

  • 12: Co-chair: Jeff Tosoian, MD, MPH, Vanderbilt University Medical Center

3:00 p.m. – 3:15 p.m.

3:15 p.m. – 3:20 p.m. Q&A

Gastrointestinal and Associated Cancers

  • 13: Co-chair: Cecilia Yeung, MD, Fred Hutchinson Cancer Center

3:20 p.m. – 3:50 p.m.

Update on EDRN Liver Clinical Utility Trial (TRACER)

  • 14: Jorge Marrero, MD, MS, University of Pennsylvania Health System

3:50 p.m. – 4:20 p.m.

Break

4:20 p.m. – 5:20 p.m.

Round Table Discussions

Round Table 1: Spatiomics & Digital Pathology

Room: Sorrell Room 1005
619 S 42nd St, Omaha, NE 68198

  • Chair: Ludmil Alexandrov, PhD, University of California, San Diego
  • Co-chair: Cecilia Yeung, MD, Fred Hutchinson Cancer Center
  • Long Cai, PhD, California Institute of Technology
  • DMCC Statistician: Yingye Zheng, PhD, Fred Hutchinson Cancer Center
  • DMCC Staff: Jackie Dahlgren, BS, Fred Hutchinson Cancer Center
  • Indu Kohaar, PhD, National Cancer Institute
  • Sidney Fu, MD, National Cancer Institute

Round Table 2: Proteogenomics

Room: Sorrell Room 2014
619 S 42nd St, Omaha, NE 68198

  • Chair: Hui Zhang, PhD, Johns Hopkins University
  • Co-chair: Mamie Lih, PhD, Johns Hopkins University
  • Tao Liu, PhD, Pacific Northwest National Laboratory (PNNL)
  • DMCC Statistician: Ying Huang, PhD, Fred Hutchinson Cancer Center
  • DMCC Staff: Stephanie Page-Lester, BS, Fred Hutchinson Cancer Center
  • Matt Young PhD, National Cancer Institute

Round Table 3: Virus Related Cancers

Room: Sorrell Room 2001
619 S 42nd St, Omaha, NE 68198

  • Chair: Erich Sturgis, PhD, Baylor College of Medicine
  • Co-chair: Anna Giuliano, PhD, H. Lee Moffit Cancer Center
  • DMCC Statistician: Yingqi Zhao, PhD, Fred Hutchinson Cancer Center
  • DMCC Staff: Suzanna Reid, PhD., Fred Hutchinson Cancer Center
  • Amanda Melillo, PhD, National Institute of Dental and Craniofacial Research
  • Wendy Wang, PhD, National Cancer Institute

Round Table 4: Academic Industrial Partnerships (tentative)

Room: Truhlsen Events Center, Room 1001 A
619 S 42nd St, Omaha, NE 68198

  • Chair: Sam Hanash, MD, MD Anderson Cancer Center
  • Co-chair: David Sidransky, MD, Johns Hopkins University
  • Andrew Hoofnagle, MD, PhD, University of Washington
  • Gerard Davis, PhD, Abbott Laboratories
  • Mark Driscoll, PhD, Intus Biosciences
  • DMCC Statistician: Ziding Feng, PhD, Fred Hutchinson Cancer Center
  • DMCC Staff: Kristin Rodgers, BA, Fred Hutchinson Cancer Center
  • Sudhir Srivastava, PhD, MPH, National Cancer Institute

5:20 p.m. – 5:40 p.m.

Attendees to Gather in Truhlsen Event Center, Room 1001 A for Summary of Round Table Discussions

5:40 p.m. – 6:40 p.m.

Summary of Round Table Discussions:

Room: Truhlsen Events Center, Room 1001 A
619 S 42nd St, Omaha, NE 68198

Round Table 1: Spatiomics & Digital Pathology

  • Chair: Ludmil Alexandrov, PhD, University of California, San Diego
  • Co-chair: Cecilia Yeung, MD, Fred Hutchinson Cancer Center
  • NCI PD: Indu Kohaar, PhD, National Cancer Institute
  • NCI PD: Sidney Fu, MD, National Cancer Institute

Round Table 2: Proteogenomics

  • Chair: Hui Zhang, PhD, Johns Hopkins University
  • Co-chair: Mamie Lih, PhD, Johns Hopkins University
  • NCI PD: Matt Young PhD, National Cancer Institute

Round Table 3: Virus Related Cancers

  • Chair: Erich Sturgis, PhD, Baylor College of Medicine
  • Co-chair: Anna Giuliano, PhD, H. Lee Moffit Cancer Center
  • NIDCR PD: Amanda Melillo, PhD, NIDCR
  • NCI PD: Wendy Wang, PhD, National Cancer Institute

Round Table 4: Academic Industrial Partnerships

  • Chair: Sam Hanash, MD, MD Anderson Cancer Center
  • Co-chair: David Sidransky, MD, Johns Hopkins University
  • NCI PD: Richard Mazurchuk, PhD, National Cancer Institute
  • NCI PD: Sudhir Srivastava, PhD, MPH, National Cancer Institute

6:40 p.m. – 6:45 p.m.

Closing Remarks

  • Arul Chinnayian, MD, PhD, University of Michigan
  • Karen Anderson, MD, PhD, Arizona State University

6:45 p.m.

EDRN Steering Committee Meeting Adjourned